4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-21-003917
Director sold 5,999 shares at $40.04 ($240,200)
- Director acquired 5,999 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kurkijarvi Kalevi · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-14 | Exercise or conversion : show line 1 in the form | +5,999 | $19.05 | $114,281 | 39,099 | D |
| 2021-01-14 | Sale : show line 2 in the form | −5,999 | $40.04 | $240,200 | 33,100 | D |
| Open-market sales · 5,999 sh · avg $40.04 · $240,200 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-01-14 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −5,999 | $19.05 | 2026-06-08 | 5,999 | 6,000 | D |
Loading xslF345X03/doc4.xml…